Delivery Order SPE2DB22D3501-SPE2DB25FVK80
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Eliquis 5 mg tablets (60-count units) with a ceiling value of $14,787.00. This firm fixed-price delivery order, which is set to be completed by August 12, 2025, will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The award represents a competitive procurement with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Eliquis 5 mg tablets (60-count units) with a ceiling value of $39,270.67. This non-competitive, firm fixed-price delivery order is scheduled for completion by June 3, 2025, and will be performed at the vendor's facility in Conshohocken, Pennsylvania. The award represents a continuation of pharmaceutical supply fulfillment under AmerisourceBergen's...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) with a ceiling value of $27,309.78. This firm fixed-price delivery order is scheduled for completion by July 11, 2025, and will be fulfilled from the contractor's location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 21, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) valued at $11,836.46. This firm fixed-price delivery order, which must be completed by April 22, 2025, represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The award utilized no set-aside provisions and was competitively awarded, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 25, 2025, for the supply of Eliquis 5 mg tablets (60-count units) with a ceiling value of $11,488.95. This firm fixed-price delivery order, which is due for completion by April 28, 2025, represents a non-set-aside competitive award with performance at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order was issued under the company's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Eliquis 5 mg tablets (60-count units) with a ceiling value of $25,763.39. This is a firm fixed price delivery order with an ultimate completion date of July 25, 2025, and represents a competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, the company's corporate headquarters....
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on April 25, 2025, for the supply of Eliquis 5 mg tablets in quantities of 60 units. This firm fixed-price delivery order, valued at $68,567.69, is scheduled for completion by April 28, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed-price contract with a ceiling value of $21,583.21. This is a non-set-aside delivery order to be completed by September 22, 2025, with performance at the vendor's Conshohocken, Pennsylvania location. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) under a firm fixed-price contract valued at $1,862.57. This competitively awarded, non-set-aside delivery order is scheduled for completion by July 29, 2025, with the place of performance located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The award represents a continuation of the...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,081.16 on June 18, 2025, for the supply of Eliquis 5 mg tablets (60-count units). This firm fixed-price delivery order is scheduled for completion by June 20, 2025, with fulfillment performed at the vendor's Conshohocken, Pennsylvania location. The award was competitively procured without set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FVK80Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Eliquis 5 mg tablets (60-count package) with a ceiling value of $5,537.99. This competitively awarded, firm fixed-price delivery order is scheduled for completion by April 25, 2025, and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting AmerisourceBergen's competitive standing as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The IDC enables the company to supply a broad range of pharmaceutical products, medical supplies, and specialty medications to support military healthcare programs and other federal customers, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's extensive portfolio of federal contracts demonstrates its critical role in the Department of Defense's medical supply chain, with the company positioned as a primary vendor under DLA's Pharmaceutical Prime Vendor Global Program framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.5k | 4/24/25 |